Research Library / Mitochondrial / Methylene Blue
Mitochondrial researchMethylene Blue
Methylthioninium chloride
A non-peptide medication with approved and investigational uses; wellness and cognitive claims are not equivalent to approved medical use. The listed community example (community oral research range) describes 0.5–1 mg/kg per administration, once daily, via oral; this is not a validated dosing recommendation. Generic vial reconstitution does not fit this presentation. For research and education only, not personal medical guidance.
Quick Reference
- Evidence
- Established drug · off-label research
- Presentation
- Not a generic reconstitution example
- Clinical context
- See cited product or study
- Diluent
- Not assigned
Methylene blue is supplied as product-specific oral or liquid formulations rather than a lyophilized peptide vial.
Research schedules
No established clinical dose, route or frequency
Human evidence is absent, limited or not confirmatoryPubMed literature| Context / phase | Amount | Schedule total | Frequency | Timing | Route | Evidence |
|---|---|---|---|---|---|---|
| Community oral research range | 0.5–1 mg/kg | Weight-dependent daily total | Once daily | Morning | Oral | Community-reported |
Repeated community reports do not establish identity, safety, effectiveness or an appropriate exposure. Component schedules do not validate a same-vial blend.
Vial calculator
Reconstitution does not fit this presentation
Methylene blue is supplied as product-specific oral or liquid formulations rather than a lyophilized peptide vial.
Supplies & vial yield
Supply total not calculated
No standardized injectable planning basis
Methylene blue is supplied as product-specific oral or liquid formulations rather than a lyophilized peptide vial.
*Conditional mass and final-volume arithmetic. No stability, sterility, safe reuse period or verified diluent quantity is established. Cleansing materials, sterile supplies, labels and sharps disposal follow the actual research procedure.
Protocol overview & research context
- Identity
- Methylene Blue · Methylthioninium chloride
- Evidence / status
- Established drug · off-label research. FDA-approved products exist for specific indications
- Clinical route, frequency & duration
Evidence landscape: No established clinical dose, route or frequency
- Community purpose
- Cellular energy, mitochondrial function, cognition, and redox-oriented research discussions.
Loading, titration and maintenance
A separate loading phase is not identified in this library entry. Titration, maintenance and stopping rules depend on the specific product or study; a listed range is not automatically an escalation plan.
Reconstitution & formulation
PROVAYBLUE is a finished IV solution. Its label warns against sodium chloride dilution because chloride reduces methylene-blue solubility; its specified dextrose dilution is product- and route-specific.
Other vehicles and approaches discussed
These instructions do not apply automatically to oral methylene-blue products, nor establish a subcutaneous or peptide-vial recipe.
- Evidence context
- Product / laboratory / report distinctions apply
- Cloudiness / gel signal
- Labeled sodium-chloride dilution incompatibility
- Product details to verify
- Verify the exact product, sequence/salt form, buffer and excipients, concentration, route, container and product-specific storage instructions.
Sources apply to the named product, laboratory method or report only. Laboratory solvents and community repetition do not establish an injectable preparation, sterility, chemical stability or a beyond-use period. No solvent-mixing or salvage recipe is provided.
Preparation references reviewed October 20, 2026.
Preparation documentation checklist
- Confirm identity, nominal content, salt form, buffer and excipients.
- Verify the actual product's diluent, amount to add and intended method.
- Calculate concentration from final solution volume, and cross-check units.
- Record lot, concentration, diluent, preparation date, storage and discard instructions.
This checklist does not replace a validated preparation procedure.
Storage, clarity & stability
- Unopened product
- Follow its documented temperature, light protection, shipping and expiration requirements.
- Prepared material
- Chemical stability and microbial safety are formulation-specific. A diluent bottle's discard period does not establish the compound's storage period.
- Visible-change context
- Labeled sodium-chloride dilution incompatibility
Unexpected cloudiness, particles or gel
For a product intended to form a clear solution, do not use or attempt to salvage unexpected persistent clouding, strings, precipitate, thickening or gel. Labeled suspensions, including some triptorelin depots, have their own expected appearance and instructions.
Why vial yield does not establish shelf life
Arithmetic portions assume the material remains usable. Chemical degradation, contamination, handling losses and required discard limits may reduce practical yield. Freezing, warming, acidifying or further diluting cannot be assumed to restore quality.
No universal refrigerated, room-temperature or 90-day beyond-use period is assigned by the calculator.
How it works
Redox-active phenothiazine affecting electron transport and monoamine metabolism
A non-peptide medication with approved and investigational uses; wellness and cognitive claims are not equivalent to approved medical use.
Community-reported purpose
Cellular energy, mitochondrial function, cognition, and redox-oriented research discussions.
Reported purposes and marketing use-cases are not an approved indication or proof of efficacy.
Clinical findings & study landscape
Evidence landscape
Protocol: No established clinical dose, route or frequency
Population: Human evidence is absent, limited or not confirmatory
Read the cited evidenceFindings apply to the tested product, population and methods. A registry listing, mechanistic study or evidence-landscape link is not itself proof of efficacy or validation of an online vial.
Safety, evidence limits & regulatory status
Compound-specific safety context
Can cause serotonin toxicity with serotonergic drugs, hemolysis in G6PD deficiency, and clinically important drug interactions.
Development and regulatory status
FDA-approved products exist for specific indications
Approval of a named product does not extend to every vial, formulation, route, blend or indication carrying a related name.
What this guide cannot establish
The library does not authenticate a product or determine a personal starting dose, missed-dose rule, restart regimen, interaction plan or combination protocol. Study schedules, community reports and vial calculations retain separate evidence labels.
Frequently asked questions
What is Methylene Blue?
A non-peptide medication with approved and investigational uses; wellness and cognitive claims are not equivalent to approved medical use.
Redox-active phenothiazine affecting electron transport and monoamine metabolism
Does vial strength mean the amount per administration?
No. A vial's label states nominal contents. The amount used in a study belongs to its assigned product and protocol. Changing vial strength changes concentration and yield, not the study's assigned amount.
Why does changing final volume change the U-100 value?
A larger final volume reduces concentration for the same mass. U-100 markings are volume measurements: one marking equals 0.01 mL. They are not biological international units of a peptide.
What happens when a calculation exceeds one syringe or vial?
Available mass and syringe capacity are separate limits. The calculator flags a result above 1 mL; it does not provide a splitting or combining technique.
Is there a loading phase or standard cycle?
A separate loading phase is not identified in this entry. Do not infer one from a range of reported amounts.
Cycle length is not established as a universal protocol.
Which diluent and storage period should this material use?
PROVAYBLUE is a finished IV solution. Its label warns against sodium chloride dilution because chloride reduces methylene-blue solubility; its specified dextrose dilution is product- and route-specific.
Calculation examples do not establish solvent compatibility, sterility or shelf life.
Where do I track or calculate a multi-phase schedule?
The Free Planner supports saved research examples and multi-phase planning. This guide's calculator is local to the page and does not save a protocol automatically.
Open Free PlannerReferences & evidence trail
- Clinical / regulatory / evidence landscapePubMed literature: Evidence landscape
- Product labelPROVAYBLUE prescribing information
Clinical sources remain attached to their studies; laboratory and community formulation sources retain their own limits. Preparation review dates do not imply that every clinical study was newly reviewed today.
Independent educational research reference. Not medical advice or an individualized dosing recommendation.